PLCXD3-ALK, a novel ALK rearrangement in lung squamous cell carcinoma and its clinical responses to ALK inhibitors
Kaidi Chen(Shenzhen Institutes of Advanced Technology), Richeng Jiang(Jilin University)
Cited by 0
Related Papers
Autophagy Impairment in App Knock-in Alzheimer’s Model Mice
|Frontiers in Aging Neuroscience|2022|34
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis
|Acta Neuropathologica Communications|2022|31